HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** A cancer peptide vaccine composed of four human leukocyte antigen (HLA)-A2 (HLA-A*02)-restricted peptides derived from four specific and separate tumor-associated antigens (TAAs) expressed by melanoma cells, with potential antineoplastic activity. Upon administration of the HLA-A2-restricted melanoma-specific peptides vaccine, the melanoma specific antigens in the vaccine activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against the HLA-A2-positive melanoma cells.

**Synonyms:** - Cancer Vaccine GRN-1201 - GRN-1201 - Peptide Cancer Vaccine GRN-1201 - Peptide Vaccine GRN-1201